1Zhao-You Tang Liver Cancer Institute & Zhongshan Hospital of Fudan University Professor of Surgery Chairman.Liver Cancer Institute of Fudan University(previous Liver Cancer Institute of Shanghai Medical University)136 Yixueyuan Road,Zhongshan Hospital,Shanghai 200032,China..Hepatocellular Carcinoma-Cause,Treatment and Metastasis[J].World Journal of Gastroenterology,2001,7(4):445-454. 被引量：214
5Lantuejoul S, Constantin B, Drabkin H, et al. Expression of VEGF, semaphorin SEMA3F, and their common receptors neuropilins NP1 and NP2 in preinvasive bronchial lesions,lung tumours,and cell lines[J]. J Pathol,2003,200(3) B:336.
6An FQ, Matsuda M, Fujii H, Matsumoto Y. Expression of vas- cular endothelial growth factor in surgical specimens of hepato- cellular carcinoma[J]. J Cancer Res ClinOncol , 2000,126 : 153.
7Mann CD, Neal CP, Garcea G, et al. Prognostic molecular markers in hepatocellular carcinoma: a systematic review[J]. Eur J Cancer, 2007,43979.
8Mosialou I,Zannis VI,Kardassis D. Regulation of human apo lipoprotein m gene expression by orphan and ligand--depend- ent nuclear receptors[J]. Biol Chem, 2010,285 ( 40 ) : 30719.
9Galluzzi L,Morselli E,Kepp O,et al. Targeting p53 to mitQ chondria for cancer therapy[-J]. Cell Cycle,2008,7(13) :1949.
10Lim SO,Kim H,Jung G. p53 inhibits tumor cell invasionvia the degradation of snail protein in hepatocellular carcinoma [J]. FEBS LETT, 2010,584(11) :2231.
